Bangalore based Strand Life Sciences entered into a partnership with the Mazumdar-Shaw Medical Foundation (MSMF) to set up the Strand at Mazumdar-Shaw (SAMS) translational lab in the Mazumdar-Shaw Centre for Translational Research (MSCTR) located at Bangalore.
“With evolving healthcare systems, it is imperative that we are constantly innovating and developing capabilities that will provide personalised treatment and quality care to the people of India. We believe this collaboration will help us foster innovation and encourage in-depth research in the genomics space and thereby provide better care for patients with cancer and other genetic diseases,” said Dr Kiran Mazumdar-Shaw, CMD, Biocon.
Strand will offer comprehensive genomic testing for cancer and other germline/hereditary conditions at highly affordable costs. In addition, the collaboration will also entail promoting research in the field of genomics, conducting medical and non-medical programmes, seminars and talks shows, assisting clinicians and scientists in performing quality research, and towards making genomics research resources and data available to scientists.
Dr Vijay Chandru, Chairman & CEO, Strand Life Sciences said, “The Mazumdar-Shaw Medical Foundation has shown great foresight and magnanimity in helping us work towards the goal of providing the leading edge of genomic medicine at affordable prices in India and elsewhere. This collaboration provides Strand with an opportunity to conduct and promote in-depth research in the field of genomic sequencing based diagnostics.
EH News Bureau
- Advertisement -
